MARYLAND: Millions of people worldwide use glucagon-like peptide-1 (GLP-1) medicines to manage type 2 diabetes and obesity, but a potential risk of a serious eye condition has ...
BERLIN: When a new infectious disease begins to spread, the time it takes to recognise the threat can make a crucial difference. Earlier detection gives health authorities a better chance to ...
WASHINGTON: COVID-19 may do more than trigger an infection with SARS-CoV-2. A new study has found that the illness can be accompanied by the reactivation of dormant viruses already present in the ...